ACET — ADICET BIO INC

Ownership history in Rangeley Capital, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which Rangeley Capital, LLC reported a position in ADICET BIO INC (ACET). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.17% (2025 Q4)
Avg. % of fund
0.11%
First filed
2025 Q3
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 25,001 -49,999 -66.7% 0.17% $211K $8.42
2025 Q3 INITIATED 75,000 — — 0.05% $61K $12.96
% of Fund (quarterly)    ACET price (monthly, adj. close)

Other funds also holding ACET

As of 2025 Q4 — sorted by position size

REGENERON PHARMACEUTICALS, INC. 1.51% Stonepine Capital Management, LLC 3Y 7Y 1.35% LUMINUS MANAGEMENT LLC 3Y 7Y 0.44% Prosight Management, LP 3Y 7Y 0.44% DAFNA Capital Management LLC 3Y 7Y 0.18% ORBIMED ADVISORS LLC 3Y 7Y 0.18% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.08% ADAR1 Capital Management, LLC 0.08% Burkehill Global Management, LP 0.03% JOHNSON & JOHNSON 3Y 0.03%
← Back to Rangeley Capital, LLC Holdings